Category Archives: SELECT

SELECT, Semaglutide

SELECT: Semaglutide Reduces CV Events and Diabetes Risk

Posted on by Dion Serna
SELECT: Semaglutide Reduces CV Events and Diabetes Risk
24
Jun

Ozempic weight loss reviews ORLANDO, Fla. — The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced cardiovascular events and reduced the risk of progression to diabetes by 73% in people with established cardiovascular disease and obesity compared with placebo, regardless of baseline A1c levels, according to two new analyses of the SELECT trial. […]

Continue reading →

You were not leaving your cart just like that, right?

Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)

Want to receive personalized offers?

Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊

Maybe later